SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-12B - Registration of securities [Section 12(b)]:
SEC Accession No. 0001193125-09-070682
Filing Date
2009-04-01
Accepted
2009-04-01 16:35:12
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM 10 d1012b.htm 10-12B 43872
2 LICENSE AGREEMENT dex105.htm EX-10.5 101298
3 PRELIMINARY INFORMATION STATEMENT dex991.htm EX-99.1 1344185
5 GRAPHIC g83276g71v62.jpg GRAPHIC 12410
6 GRAPHIC g83276g78e72.jpg GRAPHIC 14062
7 filename7.htm CORRESP 9760
  Complete submission text file 0001193125-09-070682.txt   1537299
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
Myriad Pharmaceuticals, Inc. (Filer) CIK: 0001459450 (see all company filings)

IRS No.: 263996918 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-12B | Act: 34 | File No.: 001-34275 | Film No.: 09723854
SIC: 2834 Pharmaceutical Preparations